Traditional Chinese medicine for treating viral lower respiratory tract infection

Abstract

The invention relates to a traditional Chinese medicine for treating viral lower respiratory tract infection and a preparation method thereof. The traditional Chinese medicine for treating viral lower respiratory tract infection is prepared from the following raw materials in part by weight: 3 to 6 parts of fried ephedra herb, 5 to 12 parts of gypsum, 5 to 12 parts of baical skullcap root, 5 to 12 parts of giant knotweed rhizome, 4 to 9 parts of great burdock achene, 3 to 6 parts of arisaema cum bile, 4 to 9 parts of rhizoma pinelliae preparatum and 4 to 9 parts of tangerine peel; The preparation method of the traditional Chinese medicine for treating viral lower respiratory tract infection comprises: 1) weighing the raw materials according to a mixing ratio; 2) adding water into the tangerine peel and distilling the tangerine peel to extract volatile oil; 3) filtering aqueous solution obtained after distillation, collecting filtrate, decocting medicinal slag, the fried ephedra herb, the gypsum, the baical skullcap root, the giant knotweed rhizome, the great burdock achene and the arisaema cum bile in water, filtering and obtaining filtrate; 4) mixing the filtrate and the aqueous solution, concentrating under reduced pressured, cooling, and adding ethanol; 5) filtering, recovering ethanol, concentrating under reduced pressure, drying under vacuum and obtaining dry paste; and 6) grinding the dry paste into fine powder, adding dextrin, preparing particles, drying, sieving, spraying volatile oil, uniformly mixing and bagging.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine for treating viral lower respiratory tract infection and a preparation method thereof. Background technique [0002] Respiratory tract infection is the most common disease in humans. 90% to 95% of all acute respiratory infections are caused by viruses, which are far more important than bacteria and other microorganisms. In China, 1.5 million people die of respiratory infections every year, plus other basic diseases complicated by respiratory infections. more than 3 million people. Currently the highest mortality rate in hospital is lung infection. Most of the critically ill patients with cerebrovascular disease and tumor with the top two mortality rates will eventually develop pulmonary infection and die directly from viral or fungal pneumonia. Among the top 500 best-selling drugs in the world in 2000, the sales of antiviral drugs were 7.3 billio...

AI Technical Summary

Problems solved by technology

Although Maxing Shigan Wan can be used for viral lower respiratory tract infection, its antiviral effect is not strong, and it is better than Xinliang Xuanfei, relieving asthma and relieving cough, and it is not suitable for those with excessive phlegm

Images